Patients who undergo both TAVI and complex/high-risk PCI see fewer adverse events and less procedural risk if their procedures are done using a staged rather than concomitant strategy, data from the ...
WASHINGTON, DC—Complex high-risk indicated PCI procedures (CHIP)—such as chronic total occlusions (CTOs) or calcified lesions—can be safely performed by fellows in training, according to new ...
The beneficial effect of clopidogrel monotherapy over aspirin monotherapy in patients who underwent percutaneous coronary intervention (PCI) and remained event free for 6-18 months on dual ...
Madrid, Spain – 31 August 2025: There was no benefit to modulating the intensity of antiplatelet therapy compared with standard antiplatelet therapy in high-risk patients who had undergone complex ...
DANVERS, Mass. – October 28, 2024 – Results were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference from the first completed pivotal trial on patients supported with Impella ...
Select high bleeding risk (HBR) patients can safely receive just 1 or 3 months of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) without more ischemic events, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results